AAPM Banner
  • Volume/Page
  • Keyword
  • DOI
  • Citation
  • Advanced
   
 
 
 

You are not logged in Access to this article requires a subscription. Log In

Medical Physics / Volume 39 / Issue 6 / FIFTY‐FOURTH ANNUAL MEETING OF THE AMERICAN ASSOCIATION OF PHYSICISTS IN MEDICINE / THERAPY GENERAL POSTER DISCUSSION: EXHIBIT HALL

Med. Phys. 39, 3847 (2012); http://dx.doi.org/10.1118/1.4735704 (1 page)

SU‐E‐T‐615: Quantifying the Benefit of Adaptive Fractionation

J Ramakrishnan1, D Craft2, T Bortfeld2, and J Tsitsiklis1

1MIT, Cambridge, MA
2Massachusetts General Hospital, Boston, MA

  • Abstract
Full Text: Download PDF | Rent Article () | Buy PDF (US$30) | View Cart
Purpose: To quantify the benefit of adaptive fractionation, through both theoretical test cases and patient data. Methods: We consider the effect of delivering a different fraction size based on the changes observed in the patient anatomy. Given that a fixed prescription dose must be delivered to the tumor over the course of the treatment, we find that adaptively varying the fraction size results in a lower cumulative dose to a primary organ‐at‐risk (OAR). We construct a one dimensional theoretical example by randomly varying the distance between the tumor and OAR, and simulate the benefit of adaptive fractionation in such a setting. Next, we test our methodology using contoured daily CT images from 5 prostate patients. Results: For the theoretical example, we found about a 10% decrease in dose to the OAR when using a uniformly distributed motion model and a 20% daily fraction size deviation. In general, the amount of decrease in dose to the OAR varied significantly (5–85%) for these theoretical test cases depending on the amount of motion in the anatomy, the number of fractions, and the range of fraction sizes allowed. Preliminary results from the prostate patients indicate an average reduction in dose to the rectum of 1.4%, 3.5%, and 7.0% when using 20%, 50%, and 100% daily fraction size deviations, respectively. Conclusions: Qualitatively, the theoretical example indicates that adaptive fractionation is beneficial for disease sites in which there is significant inter‐fractional motion. We also expect greater benefit when using many fractions and allowing for large daily fraction size deviations. For the prostate disease site in particular, we find that adaptive fractionation is beneficial only when allowing large daily fraction size deviations. Further research quantifying the gain for disease sites that exhibit significant inter‐fractional motion, such as rectal and cervical cancers, would be useful. Partially supported by Siemens.

© 2012 American Association of Physicists in Medicine

Digital Object Identifier
http://dx.doi.org/10.1118/1.4735704

PUBLICATION DATA

ISSN

0094-2405 (print)  

Publisher

$abstract.society.value is a Member of CrossRef American Association of Physicists in Medicine

Close

Medical Physics is an official science journal of the AAPM and of the COMP/CCPM/IOMP
William R. Hendee, Editor
Departments of Radiology, Radiation Oncology, Biophysics, Community and Public Health, Medical College of Wisconsin
One Physics Ellipse
College Park, Maryland 20740
301-209-3352

© 2013, American Association of Physicists in Medicine. Individual readers of this journal, and nonprofit libraries acting for them, are freely permited to make fair use of the material in it, such as to copy an article for use in teaching or research. (For other kinds of copying see "Copying Fees.") Permission is granted to quote from this journal in scientific works with the customary acknowledgment of the source. To reprint a figure, table, or other excerpt requires, in addition, AAPM may require that permission also be obtained from one of the authors. Address inquiries and notices to Penny Slattery, Journal Manager, Medical Physics Journal, AAPM, One Physics Ellipse, College Park, MD 20740-3846; email: journal@aapm.org.

close